← Browse by Condition
Medical Condition
bevacizumab
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06755684 Phase 2
Recruiting
Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer
Enrollment
60 pts
Location
China
Sponsor
Peng Zhang
NCT07085169 Phase 2
Recruiting
Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
Enrollment
50 pts
Location
China
Sponsor
Ruijin Hospital